Business context and reporting period
FormFactor, Inc. reported an October 6, 2026 transaction in an 8-K signed October 13, 2026. This is a transaction disclosure, not a periodic earnings report; it does not provide operating results for a reporting period.
Transaction and financial details
- FormFactor agreed to sell 2,234,887 shares of common stock to Teradyne, Inc. in a private placement.
- Aggregate cash consideration is approximately $300.0 million.
- The filing does not state the purchase price per share, the resulting ownership percentage, or the proceeds’ intended use.
Material change versus prior period
The filing provides no comparable-period financial results or other basis for assessing changes in revenue, profit, cash flow, margins, debt, or liquidity. The proposed share issuance would increase shares outstanding if completed; the filing does not quantify the resulting dilution.
Outlook, conditions, and risks
Closing is expected in the fourth quarter of fiscal 2026, subject to customary closing conditions. The shares are to be issued in a private placement relying on the Securities Act Section 4(a)(2) exemption. No earnings guidance, use-of-proceeds detail, or further transaction risks are stated in the supplied filing text.
Important facts to verify
- Whether the transaction closed, and the final closing date and cash proceeds.
- Final purchase price per share and the effect on shares outstanding and Teradyne’s ownership.
- Any additional transaction details in the October 12, 2026 press release, which is referenced as Exhibit 99.1 but not included in the supplied text.